Biotherapeutic Stocks

Shares of Vital Therapies Inc (NASDAQ: VTL), a biotherapeutic company that focuses on treatment for all forms of acute liver failure, have lost more than 60 percent over the past year, likely prompting Vetr top raters to take advantage of the recent weakness. Vetr top raters upgraded Vital...